You just read:

Abstract Highlighting New Data from the Iomab-B Pivotal Phase 3 SIERRA Trial to be Presented at 2019 ASCO Annual Meeting

News provided by

Actinium Pharmaceuticals, Inc.

May 16, 2019, 08:00 ET